Head-to-head · Cost-Efficiency Index
NuBloom vs Intimate Rose
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
NuBloom
Cost-first shoppers who want a physician-founded, whole-person GLP-1 program for women, in the 49 states it publishes as covered.
Visit NuBloomIntimate Rose
Cost-first shoppers who want existing Intimate Rose pelvic-health customers curious about its bolt-on GLP-1 program, not comparison shoppers.
Visit Intimate RoseThe verdict
NuBloom takes it, leading the Cost-Efficiency Index 54 to 53. NuBloom is a women's metabolic-health telehealth practice founded and medically led by Dr. Marianne Pinkston Mueller. Intimate Rose still earns a C — Cost-first shoppers who want existing Intimate Rose pelvic-health customers curious about its bolt-on GLP-1 program, not comparison shoppers.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs NuBloom.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | NuBloom | Intimate Rose |
|---|---|---|
| Cost-Efficiency Index | 54/100 | 53/100 |
| Semaglutide / mo | Not disclosed | $169/mo (starting dose, compounded) |
| Tirzepatide / mo | $249/mo (microdose tier, compounded) | Not disclosed |
| Semaglutide / yr (modeled) | — | $2,028 |
| Tirzepatide / yr (modeled) | $2,988 | — |
| Coverage | 49 states | Coverage not published |
| Oral / sublingual | No | Yes |
| Brand-name access | Compounded only | Compounded only |
| Rank here | #361 | #368 |
NuBloom
54/100Where the value is
- Transparent, openly published starting pricing: semaglutide $149/mo, tirzepatide $279/mo, with a cheaper $249/mo microdose tirzepatide option
- Founded and medically led by a named, identifiable physician (Dr. Marianne Pinkston Mueller)
- Full state-coverage list published and independently countable: 49 states, all except Mississippi
The tradeoffs
- Compounding pharmacy partner is never named anywhere on the site — only 'a state-licensed sterile compounding pharmacy partner'
- NuBloom's own independent LegitScript status isn't distinctly confirmed; the certification language attaches to its telehealth-platform partner, Telegra
Intimate Rose
53/100Where the value is
- A real, working GLP-1 telehealth funnel exists (not a dead link or vaporware page)
- The quiz states 'No payment to get started', so shoppers can get a personalized quote before committing
- Backed by an established, non-fly-by-night e-commerce brand with an existing customer base and content library
The tradeoffs
- GLP-1 is a secondary bolt-on to a pelvic-health device business, not this company's core competency — no dedicated GLP-1 clinical infrastructure is visible on the public site
- Only one undifferentiated price point ($169/month) is published — no dose tiers, no separate semaglutide vs. tirzepatide pricing, no fee itemization
Regulatory note: the FDA issued a warning letter to Intimate Rose in September 2025. We still list and link to Intimate Rose; you should know the letter is on the public record before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.